Results 21 to 30 of about 18,308 (133)

Prostate artery EmbolisAtion Safety and efficacY: Preliminary and foLlow‐Up urodynamic Studies (P‐EASY PLUS)

BJU International, EarlyView.
Objective To assess the efficacy of prostate artery embolisation (PAE) in the management of obstructive benign prostatic hyperplasia (BPH) by conducting formal urodynamic studies. Methods Patients with symptomatic BPH underwent baseline assessments, including urodynamic evaluation, followed by PAE. Follow‐up International Prostate Symptom Scores (IPSS),
Nicholas Brown, Sepinoud Firouzmand, Anthony Kiosoglous, Stephanie Castree, Duncan Walker, Rhiannon McBean, Boon Kua, Troy Gianduzzo, Rachel Esler, Peter Campbell, Joseph Schoeman, John Yaxley   +11 more
wiley   +1 more source

What has the COVID‐19 pandemic taught us about safety of surgical wait times in urological oncology?

BJU International, EarlyView.
Objectives To review papers assessing the impact of surgical delay in relation to the COVID‐19 pandemic, and evaluate what has been learnt about the safety of surgical waiting times in urological oncology. Patients and Methods Medline and Web of Science were searched for studies published between 1 January 2020 and 1 November 2024.
James P. Blackmur, Chiara Re, Grant D. Stewart   +2 more
wiley   +1 more source

Endothelial‐Mesenchymal Transition in Tumor Microenvironment Promotes Neuroendocrine Differentiation of Prostate Cancer

Cancer Science, EarlyView.
Endothelial‐mesenchymal transition (EndoMT) contributes to neuroendocrine differentiation (NED) in prostate cancer. Using in vitro co‐culture models, we show that EndoMTed endothelial cells promote NED in prostate cancer cells via GM‐CSF signaling. These findings reveal a previously unrecognized paracrine mechanism by which the tumor microenvironment ...
Takumi Kageyama, Manabu Kato, Shiori Miyachi, Xin Bao, Sho Sekito, Yusuke Sugino, Shinichiro Higashi, Takeshi Sasaki, Kouhei Nishikawa, Yasuhiro Murakawa, Masatoshi Watanabe, Takahiro Inoue   +11 more
wiley   +1 more source

Recombinant Activated Factor VIIa Combined With Tranexamic Acid Control Haemostasis in Patients With Severe Factor XI Deficiency Undergoing Urological Procedures

Haemophilia, EarlyView.
ABSTRACT Introduction Patients with severe Factor XI deficiency face unique challenges during urological procedures due to an elevated risk of bleeding, balanced against the use of tranexamic acid (TXA), which may form blood clots. Given the limitations associated with plasma‐based treatment, there have been reports of successful and safe off‐label use
Neta Sternbach, Yaron Ehrlich, Anfisa Stenevsky, Daniel Saidian, Darawsha Abd Elhalim, Jack Baniel, Pia Raanani, Galia Spectre   +7 more
wiley   +1 more source

The impact of UroLift implants on prostate MRI imaging

UroPrecision, EarlyView.
Jesse Persily, Angela Tong, Wei Phin Tan
wiley   +1 more source

Interobserver reproducibility of a hybrid three‐tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study

Histopathology, EarlyView.
Hybrid grading of papillary nonmuscle invasive bladder cancer showed substantial agreement as assessed by interrater kappa values. This suggests that urologic pathologists can readily adapt to using a three‐tier hybrid grading system. Aims A hybrid‐three tier system with low grade (LG), high grade‐ G2 (HG‐G2), high grade‐ G3 (HG‐G3) has been proposed ...
Michelle R. Downes, Katherine Lajkosz, Ferran Algaba, Yves Allory, Mahul B. Amin, Liang Cheng, Sangeeta Desai, Markus Eckstein, Arndt Hartmann, Antonio Lopez‐Beltran, Sebastian Mannweiler, Maurits L. van Montfoort, Jon Oxley, Gladell P. Paner, Hemamali Samaratunga, Steven Shen, Joshua Warrick, Sean R. Williamson, Sara E. Wobker, Theodorus H. van der Kwast   +19 more
wiley   +1 more source

Frontiers of Ultrasound Technology in Prostate Cancer Treatment

International Journal of Urology, EarlyView.
ABSTRACT Focal therapy is a minimally invasive alternative treatment for localized prostate cancer (PC) aiming to achieve oncological control while preserving urinary and sexual functions. High‐intensity focused ultrasound (HIFU) and high‐intensity directional ultrasound (HIDU) enable precise prostate ablation guided by real‐time transrectal ultrasound
Sunao Shoji, Kumpei Takahashi, Jun Naruse, Yoshiaki Kawamura   +3 more
wiley   +1 more source

Conducting Eye‐Tracking Research in Acute Care: A Scoping Review of Ethical, Feasibility and Acceptability Challenges

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim To identify and synthesise the ethical, feasibility and acceptability challenges associated with implementing eye‐tracking research with clinicians in acute care settings and to explore strategies to address these concerns. Design Scoping review using the Joanna Briggs Institute methodology.
Patrick Lavoie, Amélie Doherty, Lysanne Pariseau, Julie Allard, Élodie Petit, Delphine Roigt, Sophia Merisier, Maude Crétaz, Imène Khetir, Tanya Mailhot   +9 more
wiley   +1 more source

Selectivity and anti‐tumor immune elevation by vascular‐targeted photodynamic therapy of mouse orthotopic bladder cancer model

Photochemistry and Photobiology, EarlyView.
Vascular‐targeted photodynamic therapy (VTP) using the photosensitizer WST11 is a non‐surgical tumor ablation approach. Light activation of WST11 leads to excessive generation of reactive oxygen species, which causes tumor vascular arrest, followed by destruction of tumor blood vessels and tumor necrosis.
Jie Chen, Natalia Kudinova, Rebecca Dubrovsky, Jasmine Thomas, Karan Nagar, Lucas Nogueira, Avigdor Scherz, Kwanghee Kim, Jonathan Coleman   +8 more
wiley   +1 more source

Cost‐Effectiveness Analysis of Risky Health Interventions: Moving Beyond Risk Neutrality

Ratio, EarlyView.
ABSTRACT Cost‐effectiveness analysis for health interventions is traditionally conducted in a risk‐neutral way, insensitive to risk attitudes in the population, which are potentially non‐neutral. While the standard outcome metric of quality‐adjusted life years (QALYs) aims to be deferential to people's valuations of health states, cost‐effectiveness ...
Johanna Thoma
wiley   +1 more source